Dimazon 50 mg/ml Injektionslösung für Rinder, Pferde, Hunde und Katzen
Dimazon 50 mg/ml Injektionslösung für Rinder, Pferde, Hunde und Katzen
Authorised
- Furosemide
Product identification
Medicine name:
Dimazon 50 mg/ml Injektionslösung für Rinder, Pferde, Hunde und Katzen
Active substance:
- Furosemide
Target species:
-
Dog
-
Cat
-
Cattle
-
Horse
Route of administration:
-
Intramuscular use
-
Intravenous use
Product details
Active substance and strength:
-
Furosemide50.00/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Intravenous use
-
Cattle
-
Meat and offal1day
-
Milk24hour
-
-
Horse
-
Meat and offal1day
-
Milk24hour
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QC03CA01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Austria
Package description:
- Available only in German
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Intervet Ges.m.b.H.
Marketing authorisation date:
Manufacturing sites for batch release:
- Intervet International GmbH
Responsible authority:
- Austrian Agency For Health And Food Safety
Authorisation number:
- 15262
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Package Leaflet
This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 9/08/2023
Updated on: 23/03/2026
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 9/08/2023
Updated on: 23/03/2026
Labelling
This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 9/08/2023
Updated on: 23/03/2026